Tuesday, August 16, 2022
wellness India Expo
Home Tags Lupin

Tag: Lupin

Lupin Diagnostics launches its first regional reference lab in Patna

Company is expanding its diagnostics footprint in East India

Lupin registers net loss of Rs 512 crore in Q4 of...

The company had posted a net profit of Rs 464 crore in the corresponding quarter last fiscal.

Lupin launches its Reference Laboratory in Guwahati

Expanding diagnostics business footprint in North East India

Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance

Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)

Lupin signs licensing deal with Alvion to market Cardiometabolic drugs in...

By commercializing cardiometabolic drugs in the Southeast Asian region, Lupin will play a significant role in improving the quality of healthcare

Lupin launches its first reference laboratory in East India

Lupin Diagnostics is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region

Lupin signs distribution agreement with Medis for orphan drug, NaMuscla

Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders in Central and Eastern European territories

Budget 2022: “Focus must be on infrastructure and investment”

Ramesh Swaminathan, Executive Director, Global CFO & Head Corporate Affairs, Lupin Limited lists his expectations from the budget 2022

Lupin announces launch of its diagnostics business

The company has established a state-of- the-art 45,000 sq. ft National Reference Laboratory in Navi Mumbai

Pharma industry reiterates its commitment to US$ 130 billon by 2030

Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance